| PERIOD ENDING |
31-Oct-09 |
31-Jul-09 |
30-Apr-09 |
31-Jan-09 |
| Total Revenue |
99,411,000 |
100,910,000 |
94,242,000 |
109,116,000 |
| Cost of Revenue |
73,805,000 |
75,153,000 |
70,388,000 |
82,601,000 |
|
| Gross Profit |
25,606,000 |
25,757,000 |
23,854,000 |
26,515,000 |
|
| Operating Expenses |
| Research Development |
-
|
-
|
-
|
-
|
| Selling General and Administrative |
20,013,000 |
19,875,000 |
18,637,000 |
20,138,000 |
| Non Recurring |
-
|
-
|
-
|
-
|
| Others |
-
|
-
|
-
|
-
|
| |
| Total Operating Expenses |
-
|
-
|
-
|
-
|
|
|
| Operating Income or Loss |
5,593,000 |
5,882,000 |
5,217,000 |
6,377,000 |
|
| Income from Continuing Operations |
| Total Other Income/Expenses Net |
35,000 |
42,000 |
51,000 |
68,000 |
| Earnings Before Interest And Taxes |
5,628,000 |
5,924,000 |
5,268,000 |
6,445,000 |
| Interest Expense |
510,000 |
515,000 |
518,000 |
560,000 |
| Income Before Tax |
5,118,000 |
5,409,000 |
4,750,000 |
5,885,000 |
| Income Tax Expense |
1,758,000 |
1,853,000 |
1,603,000 |
1,959,000 |
| Minority Interest |
(338,000) |
117,000 |
(117,000) |
(134,000) |
| |
| Net Income From Continuing Ops |
3,360,000 |
3,673,000 |
3,030,000 |
3,792,000 |
|
| Non-recurring Events |
| Discontinued Operations |
(7,000) |
(7,000) |
(8,000) |
-
|
| Extraordinary Items |
-
|
-
|
-
|
-
|
| Effect Of Accounting Changes |
-
|
-
|
-
|
-
|
| Other Items |
-
|
-
|
-
|
-
|
|
|
| Net Income |
3,015,000 |
3,666,000 |
3,022,000 |
3,792,000 |
| Preferred Stock And Other Adjustments |
224,000 |
(224,000) |
-
|
-
|
|
| Net Income Applicable To Common Shares |
$3,239,000 |
$3,442,000 |
$3,022,000 |
$3,792,000 |
|